Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study
暂无分享,去创建一个
M. Ogura | K. Izutsu | K. Tobinai | K. Hatake | S. Sakamoto | Masanori Nishimura | M. Hoshino | M. Nishimura